Remove Human Resources Remove Operations Remove Pharmaceuticals Remove Positioning
article thumbnail

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Strategy Driven

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries.

Tactics 51
article thumbnail

Introducing 100 Coaches: Pay It Forward Champions

Marshall Goldsmith

a holding company that operates seven distinct business. Agapol Na Songkhla – Chief People Officer and Executive Vice President of Human Capital Group at Thai Beverage (ThaiBev). Operations Group Baring Private Equity. Deborah Borg – Chief Human Resources & Communications Officer, Bunge Limited.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Systems Need to Completely Reassess How They Manage Costs

Harvard Business Review

hospitals and health systems experienced an average 39% reduction in their operating margins from 2015 to 2017. Cost reduction requires an honest and thorough reassessment of everything the health system does and ultimately, a change in the organization’s operating culture. PM Images/Getty Images. ” Clearly, more is needed.

Cost 9
article thumbnail

The 3 Essential Jobs That Most Retention Programs Ignore

Harvard Business Review

For more than a decade, leading human resource strategists have hit on a recurring theme: You want your star players working in the roles that matter most to the business. As a result, these companies risk losing highly effective people in positions that have much greater impact on performance than many leaders realize.

article thumbnail

Predictive Medicine Depends on Analytics

Harvard Business Review

Energy, agriculture, insurance, retail, human resources — no industry is unaffected. The positions are there for the taking. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. But not for long.